Melody Swartz

Melody Swartz

University of Chicago

H-index: 97

North America-United States

About Melody Swartz

Melody Swartz, With an exceptional h-index of 97 and a recent h-index of 63 (since 2020), a distinguished researcher at University of Chicago, specializes in the field of bioengineering.

His recent articles reflect a diverse array of research interests and contributions to the field:

Methods and systems for detection and analysis of angiotensin binding antibodies

Engineering challenges and opportunities in autologous cellular cancer immunotherapy

Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity

Block copolymers and uses thereof

1209 Mechanisms of post-immunotherapy efficacy enhancement by tumor lymphangiogenesis

Prophylactic and therapeutic use of synthetically glycosylated antigens to limit allergic airway disease

VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination

TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells

Melody Swartz Information

University

Position

Professor of Molecular Engineering

Citations(all)

34313

Citations(since 2020)

12996

Cited By

27503

hIndex(all)

97

hIndex(since 2020)

63

i10Index(all)

160

i10Index(since 2020)

148

Email

University Profile Page

University of Chicago

Google Scholar

View Google Scholar Profile

Melody Swartz Skills & Research Interests

bioengineering

Top articles of Melody Swartz

Title

Journal

Author(s)

Publication Date

Methods and systems for detection and analysis of angiotensin binding antibodies

2024/2/8

Engineering challenges and opportunities in autologous cellular cancer immunotherapy

Colleen R Foley

Sheridan L Swan

Melody A Swartz

2024/1/15

Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity

Science Advances

Seounghun Kang

Aslan Mansurov

Trevin Kurtanich

Hye Rin Chun

Anna J Slezak

...

2023/11/29

Block copolymers and uses thereof

2023/5/3

1209 Mechanisms of post-immunotherapy efficacy enhancement by tumor lymphangiogenesis

Colleen Foley

Lambert Potin

Trevin Kurtanic

Melody Swartz

2023/11/1

Prophylactic and therapeutic use of synthetically glycosylated antigens to limit allergic airway disease

The Journal of Immunology

Jorge E Gomez Medellin

Trevor Wai-Ming Ung

Trevin Robert Kurtanich

Joseph William Reda

Thomas Wang

...

2023/5/1

VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination

The Journal of Immunology

Trevin Robert Kurtanich

Jorge Emiliano Gomez Medellin

Melody A Swartz

2023/5/1

TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells

The Journal of Immunology

Renata Mezyk-Kopec

Lambert Potin

J Emiliano Gomez Medellin

Calixto M Salles

Melody A Swartz

2023/9/1

Tumor lymphangiogenesis sensitizes melanomas to the immunological effects of radiotherapy but also disrupts the local lymphatic vasculature

Cancer Research

Anish Mukherjee

Nikolaos Mitrousis

Mari Stella Sasso

Margo MacDonald

Ainhoa Arina

...

2023/4/4

Membrane-localized neoantigens predict the efficacy of cancer immunotherapy

Cell Reports Medicine

Zoe Goldberger

Sylvie Hauert

Kevin Chang

Trevin Kurtanich

Aaron T Alpar

...

2023/8/15

Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies

2023/2/7

Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents

Blood Advances

Margo E MacDonald

Rachel K Weathered

Emma C Stewart

Alexandra I Magold

Anish Mukherjee

...

2022/12/27

VEGFR3-driven pulmonary lymphangiogenesis exacerbates induction of bronchus-associated lymphoid tissue in allergic airway disease

The Journal of Immunology

Jorge E Gomez Medellin

Maile Kananiokala Hollinger

Jillian Rosenberg

Kelly Blaine

Trevin Kurtanich

...

2022/5/1

Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses

Cell reports

Peter Deak

Bradley Studnitzer

Trevor Ung

Rachel Steinhardt

Melody Swartz

...

2022/11/1

Pathogenic exploitation of lymphatic vessels

Alexandra I Magold

Melody A Swartz

2022/3/12

Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity

Science Advances

Priscilla S Briquez

Sherin J Rouhani

Jovian Yu

Athalia R Pyzer

Jonathan Trujillo

...

2022/10/7

Lymphangiogenesis for therapeutic immunomodulation

2022/2/17

Tumor cell-surface binding of immune stimulating polymeric glyco-adjuvant via cysteine-reactive pyridyl disulfide promotes antitumor immunity

ACS Central Science

Anna J Slezak

Aslan Mansurov

Michal M Raczy

Kevin Chang

Aaron T Alpar

...

2022/10/7

Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker

Nature Biomedical Engineering

Aslan Mansurov

Peyman Hosseinchi

Kevin Chang

Abigail L Lauterbach

Laura T Gray

...

2022/7

Membrane-Localized Mutations Predict the Efficacy of Cancer Immunotherapy

medRxiv

Priscilla S Briquez

Sylvie Hauert

Zoe Goldberger

Trevin Kurtanich

Aaron T Alpar

...

2022/5/29

See List of Professors in Melody Swartz University(University of Chicago)